Alzheimer's Disease and other dementias affect over 50 million people worldwide. Early intervention is crucial. The sooner it's diagnosed, the better the disease's progression can be slowed, allowing for more time with an increased quality of life.
The Jacobs School of Medicine and Biomedical Sciences is among 72 sites nationwide that are recruiting patients for a 12-week, randomized, placebo-controlled drug trial for the first treatment designed to benefit patients with mild-to-moderate Lewy body dementia (LBD).
Bruce R. Troen, MD, professor of medicine and chief of the Division of Geriatrics and Palliative Medicine, was honored by the Amherst Senior Citizens Foundation (ASCF) with its Senior Leadership Award.
June is Alzheimer’s & Brain Awareness Month, sponsored by the Alzheimer’s Association. Memory issues and other forms of dementia affect more than 50 million people around the world, according to the association, highlighting the extent of these conditions – and the importance of making strides to staunch and reverse their progression.
Kinga Szigeti MD, PhD, is the founding director of the Alzheimer’s Disease and Memory Disorders Center and the Translational Genomics Research Laboratory in the Jacobs School of Medicine and Biomedical Sciences. The Center was recently designated a Center of Excellence for Alzheimer’s disease by the New York State Department of Health.
A preclinical study by researchers in the Department of Medicine’s Division of Geriatrics and Palliative Medicine has revealed that brief periods of intense physical activity can be safely administered at advanced age and has the potential to reverse frailty.
To meet Western New York’s growing need for quality care for Alzheimer’s disease and related disorders, the Alzheimer’s Disease and Memory Disorders Center has expanded its clinics in Buffalo and Williamsville.